nodes	percent_of_prediction	percent_of_DWPC	metapath
Indomethacin—ABCB1—peripheral nervous system neoplasm	0.148	1	CbGaD
Indomethacin—ABCC6—Dactinomycin—peripheral nervous system neoplasm	0.0886	0.144	CbGbCtD
Indomethacin—ABCC6—Cisplatin—peripheral nervous system neoplasm	0.0509	0.083	CbGbCtD
Indomethacin—ABCC6—Etoposide—peripheral nervous system neoplasm	0.05	0.0815	CbGbCtD
Indomethacin—AKR1C3—Doxorubicin—peripheral nervous system neoplasm	0.0454	0.074	CbGbCtD
Indomethacin—ABCC6—Doxorubicin—peripheral nervous system neoplasm	0.0341	0.0556	CbGbCtD
Indomethacin—UGT2B7—Epirubicin—peripheral nervous system neoplasm	0.0267	0.0434	CbGbCtD
Indomethacin—ABCC3—Vincristine—peripheral nervous system neoplasm	0.0262	0.0427	CbGbCtD
Indomethacin—ABCC1—Dactinomycin—peripheral nervous system neoplasm	0.0261	0.0426	CbGbCtD
Indomethacin—ABCC3—Cisplatin—peripheral nervous system neoplasm	0.0245	0.0399	CbGbCtD
Indomethacin—ABCC3—Etoposide—peripheral nervous system neoplasm	0.024	0.0392	CbGbCtD
Indomethacin—ABCC1—Epirubicin—peripheral nervous system neoplasm	0.0189	0.0309	CbGbCtD
Indomethacin—UGT1A1—Etoposide—peripheral nervous system neoplasm	0.018	0.0293	CbGbCtD
Indomethacin—ABCC3—Doxorubicin—peripheral nervous system neoplasm	0.0164	0.0267	CbGbCtD
Indomethacin—ABCC1—Vincristine—peripheral nervous system neoplasm	0.0161	0.0262	CbGbCtD
Indomethacin—ABCC1—Etoposide—peripheral nervous system neoplasm	0.0148	0.024	CbGbCtD
Indomethacin—ABCC2—Vincristine—peripheral nervous system neoplasm	0.0119	0.0194	CbGbCtD
Indomethacin—ABCC2—Cisplatin—peripheral nervous system neoplasm	0.0111	0.0181	CbGbCtD
Indomethacin—PTGS2—Cisplatin—peripheral nervous system neoplasm	0.011	0.0179	CbGbCtD
Indomethacin—ABCC2—Etoposide—peripheral nervous system neoplasm	0.0109	0.0178	CbGbCtD
Indomethacin—PTGS2—Etoposide—peripheral nervous system neoplasm	0.0108	0.0176	CbGbCtD
Indomethacin—ABCC1—Doxorubicin—peripheral nervous system neoplasm	0.0101	0.0164	CbGbCtD
Indomethacin—PTGS1—Etoposide—peripheral nervous system neoplasm	0.00912	0.0149	CbGbCtD
Indomethacin—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0091	0.0148	CbGbCtD
Indomethacin—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0091	0.0148	CbGbCtD
Indomethacin—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.00872	0.0142	CbGbCtD
Indomethacin—ABCC2—Doxorubicin—peripheral nervous system neoplasm	0.00745	0.0121	CbGbCtD
Indomethacin—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.00631	0.0103	CbGbCtD
Indomethacin—ABCB1—Vincristine—peripheral nervous system neoplasm	0.00389	0.00633	CbGbCtD
Indomethacin—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.00373	0.00609	CbGbCtD
Indomethacin—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.00362	0.00591	CbGbCtD
Indomethacin—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00356	0.0058	CbGbCtD
Indomethacin—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00243	0.00396	CbGbCtD
Indomethacin—PPARG—Irinotecan—Topotecan—peripheral nervous system neoplasm	0.000991	0.283	CbGdCrCtD
Indomethacin—ABCC6—Podofilox—Etoposide—peripheral nervous system neoplasm	0.000863	0.247	CbGdCrCtD
Indomethacin—AKR1C3—Podofilox—Etoposide—peripheral nervous system neoplasm	0.000754	0.216	CbGdCrCtD
Indomethacin—AKR1C3—Vinblastine—Vincristine—peripheral nervous system neoplasm	0.000519	0.148	CbGdCrCtD
Indomethacin—PPARG—Teniposide—Etoposide—peripheral nervous system neoplasm	0.000371	0.106	CbGdCrCtD
Indomethacin—PLA2G2A—tongue—peripheral nervous system neoplasm	0.000316	0.117	CbGeAlD
Indomethacin—PPARG—forelimb—peripheral nervous system neoplasm	0.000304	0.112	CbGeAlD
Indomethacin—PTGR2—trigeminal ganglion—peripheral nervous system neoplasm	0.000273	0.101	CbGeAlD
Indomethacin—PTGDR2—cerebellum—peripheral nervous system neoplasm	0.00018	0.0664	CbGeAlD
Indomethacin—GLO1—trigeminal ganglion—peripheral nervous system neoplasm	0.000169	0.0624	CbGeAlD
Indomethacin—GLO1—parotid gland—peripheral nervous system neoplasm	0.000159	0.0589	CbGeAlD
Indomethacin—PLA2G2A—trigeminal ganglion—peripheral nervous system neoplasm	0.000157	0.058	CbGeAlD
Indomethacin—CXCL8—trigeminal ganglion—peripheral nervous system neoplasm	0.000155	0.0575	CbGeAlD
Indomethacin—AKR1C3—trigeminal ganglion—peripheral nervous system neoplasm	0.000122	0.0451	CbGeAlD
Indomethacin—PTGR2—cerebellum—peripheral nervous system neoplasm	0.000119	0.0441	CbGeAlD
Indomethacin—AKR1C3—parotid gland—peripheral nervous system neoplasm	0.000115	0.0425	CbGeAlD
Indomethacin—Constipation—Vincristine—peripheral nervous system neoplasm	8.89e-05	0.000503	CcSEcCtD
Indomethacin—Pain—Vincristine—peripheral nervous system neoplasm	8.89e-05	0.000503	CcSEcCtD
Indomethacin—Osteoarthritis—Doxorubicin—peripheral nervous system neoplasm	8.88e-05	0.000503	CcSEcCtD
Indomethacin—Gastrointestinal haemorrhage—Doxorubicin—peripheral nervous system neoplasm	8.88e-05	0.000503	CcSEcCtD
Indomethacin—Diplopia—Doxorubicin—peripheral nervous system neoplasm	8.88e-05	0.000503	CcSEcCtD
Indomethacin—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	8.88e-05	0.000503	CcSEcCtD
Indomethacin—Rash—Melphalan—peripheral nervous system neoplasm	8.86e-05	0.000501	CcSEcCtD
Indomethacin—Dermatitis—Melphalan—peripheral nervous system neoplasm	8.85e-05	0.000501	CcSEcCtD
Indomethacin—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	8.82e-05	0.000499	CcSEcCtD
Indomethacin—Chest pain—Etoposide—peripheral nervous system neoplasm	8.78e-05	0.000497	CcSEcCtD
Indomethacin—PTGS1—ganglion—peripheral nervous system neoplasm	8.77e-05	0.0325	CbGeAlD
Indomethacin—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	8.77e-05	0.000497	CcSEcCtD
Indomethacin—Anorexia—Cisplatin—peripheral nervous system neoplasm	8.76e-05	0.000496	CcSEcCtD
Indomethacin—Discomfort—Etoposide—peripheral nervous system neoplasm	8.68e-05	0.000491	CcSEcCtD
Indomethacin—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	8.65e-05	0.00049	CcSEcCtD
Indomethacin—Hypotension—Cisplatin—peripheral nervous system neoplasm	8.59e-05	0.000486	CcSEcCtD
Indomethacin—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	8.57e-05	0.000485	CcSEcCtD
Indomethacin—Urticaria—Alitretinoin—peripheral nervous system neoplasm	8.57e-05	0.000485	CcSEcCtD
Indomethacin—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	8.53e-05	0.000483	CcSEcCtD
Indomethacin—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	8.53e-05	0.000483	CcSEcCtD
Indomethacin—Nausea—Topotecan—peripheral nervous system neoplasm	8.52e-05	0.000482	CcSEcCtD
Indomethacin—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	8.5e-05	0.000481	CcSEcCtD
Indomethacin—Gastritis—Epirubicin—peripheral nervous system neoplasm	8.5e-05	0.000481	CcSEcCtD
Indomethacin—Confusional state—Etoposide—peripheral nervous system neoplasm	8.49e-05	0.000481	CcSEcCtD
Indomethacin—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	8.47e-05	0.000479	CcSEcCtD
Indomethacin—Nausea—Tretinoin—peripheral nervous system neoplasm	8.45e-05	0.000479	CcSEcCtD
Indomethacin—Nausea—Isotretinoin—peripheral nervous system neoplasm	8.45e-05	0.000479	CcSEcCtD
Indomethacin—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	8.42e-05	0.000477	CcSEcCtD
Indomethacin—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	8.35e-05	0.000473	CcSEcCtD
Indomethacin—Asthenia—Dactinomycin—peripheral nervous system neoplasm	8.35e-05	0.000473	CcSEcCtD
Indomethacin—Nausea—Melphalan—peripheral nervous system neoplasm	8.34e-05	0.000472	CcSEcCtD
Indomethacin—Asthma—Epirubicin—peripheral nervous system neoplasm	8.3e-05	0.00047	CcSEcCtD
Indomethacin—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	8.25e-05	0.000467	CcSEcCtD
Indomethacin—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	8.24e-05	0.000467	CcSEcCtD
Indomethacin—Tachycardia—Etoposide—peripheral nervous system neoplasm	8.22e-05	0.000465	CcSEcCtD
Indomethacin—Abdominal pain—Vincristine—peripheral nervous system neoplasm	8.21e-05	0.000465	CcSEcCtD
Indomethacin—Body temperature increased—Vincristine—peripheral nervous system neoplasm	8.21e-05	0.000465	CcSEcCtD
Indomethacin—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	8.19e-05	0.000464	CcSEcCtD
Indomethacin—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	8.14e-05	0.000461	CcSEcCtD
Indomethacin—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	8.11e-05	0.000459	CcSEcCtD
Indomethacin—Anorexia—Etoposide—peripheral nervous system neoplasm	8.02e-05	0.000454	CcSEcCtD
Indomethacin—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	8e-05	0.000453	CcSEcCtD
Indomethacin—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	7.99e-05	0.000452	CcSEcCtD
Indomethacin—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	7.96e-05	0.000451	CcSEcCtD
Indomethacin—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	7.95e-05	0.00045	CcSEcCtD
Indomethacin—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	7.88e-05	0.000446	CcSEcCtD
Indomethacin—Hypotension—Etoposide—peripheral nervous system neoplasm	7.87e-05	0.000445	CcSEcCtD
Indomethacin—Gastritis—Doxorubicin—peripheral nervous system neoplasm	7.86e-05	0.000445	CcSEcCtD
Indomethacin—Pain—Cisplatin—peripheral nervous system neoplasm	7.86e-05	0.000445	CcSEcCtD
Indomethacin—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	7.83e-05	0.000444	CcSEcCtD
Indomethacin—Asthenia—Alitretinoin—peripheral nervous system neoplasm	7.74e-05	0.000438	CcSEcCtD
Indomethacin—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	7.73e-05	0.000438	CcSEcCtD
Indomethacin—Asthma—Doxorubicin—peripheral nervous system neoplasm	7.68e-05	0.000435	CcSEcCtD
Indomethacin—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	7.67e-05	0.000434	CcSEcCtD
Indomethacin—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	7.66e-05	0.000434	CcSEcCtD
Indomethacin—Pruritus—Alitretinoin—peripheral nervous system neoplasm	7.63e-05	0.000432	CcSEcCtD
Indomethacin—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	7.57e-05	0.000429	CcSEcCtD
Indomethacin—Paraesthesia—Etoposide—peripheral nervous system neoplasm	7.56e-05	0.000428	CcSEcCtD
Indomethacin—Weight increased—Epirubicin—peripheral nervous system neoplasm	7.55e-05	0.000428	CcSEcCtD
Indomethacin—Dyspnoea—Etoposide—peripheral nervous system neoplasm	7.5e-05	0.000425	CcSEcCtD
Indomethacin—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	7.49e-05	0.000424	CcSEcCtD
Indomethacin—Somnolence—Etoposide—peripheral nervous system neoplasm	7.48e-05	0.000424	CcSEcCtD
Indomethacin—Asthenia—Vincristine—peripheral nervous system neoplasm	7.46e-05	0.000422	CcSEcCtD
Indomethacin—Drowsiness—Epirubicin—peripheral nervous system neoplasm	7.4e-05	0.000419	CcSEcCtD
Indomethacin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	7.4e-05	0.000419	CcSEcCtD
Indomethacin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	7.38e-05	0.000418	CcSEcCtD
Indomethacin—GLO1—cerebellum—peripheral nervous system neoplasm	7.36e-05	0.0272	CbGeAlD
Indomethacin—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	7.34e-05	0.000415	CcSEcCtD
Indomethacin—Rash—Dactinomycin—peripheral nervous system neoplasm	7.33e-05	0.000415	CcSEcCtD
Indomethacin—Decreased appetite—Etoposide—peripheral nervous system neoplasm	7.32e-05	0.000414	CcSEcCtD
Indomethacin—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	7.29e-05	0.000413	CcSEcCtD
Indomethacin—Renal failure—Epirubicin—peripheral nervous system neoplasm	7.27e-05	0.000412	CcSEcCtD
Indomethacin—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	7.26e-05	0.000411	CcSEcCtD
Indomethacin—SLC22A8—trigeminal ganglion—peripheral nervous system neoplasm	7.26e-05	0.0269	CbGeAlD
Indomethacin—Fatigue—Etoposide—peripheral nervous system neoplasm	7.26e-05	0.000411	CcSEcCtD
Indomethacin—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	7.25e-05	0.000411	CcSEcCtD
Indomethacin—Jaundice—Epirubicin—peripheral nervous system neoplasm	7.21e-05	0.000408	CcSEcCtD
Indomethacin—Stomatitis—Epirubicin—peripheral nervous system neoplasm	7.21e-05	0.000408	CcSEcCtD
Indomethacin—Pain—Etoposide—peripheral nervous system neoplasm	7.2e-05	0.000408	CcSEcCtD
Indomethacin—Constipation—Etoposide—peripheral nervous system neoplasm	7.2e-05	0.000408	CcSEcCtD
Indomethacin—Dizziness—Alitretinoin—peripheral nervous system neoplasm	7.13e-05	0.000404	CcSEcCtD
Indomethacin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	7.11e-05	0.000403	CcSEcCtD
Indomethacin—Sweating—Epirubicin—peripheral nervous system neoplasm	7.09e-05	0.000402	CcSEcCtD
Indomethacin—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	7.09e-05	0.000402	CcSEcCtD
Indomethacin—Haematuria—Epirubicin—peripheral nervous system neoplasm	7.05e-05	0.000399	CcSEcCtD
Indomethacin—Weight increased—Doxorubicin—peripheral nervous system neoplasm	6.99e-05	0.000396	CcSEcCtD
Indomethacin—Epistaxis—Epirubicin—peripheral nervous system neoplasm	6.98e-05	0.000395	CcSEcCtD
Indomethacin—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	6.94e-05	0.000393	CcSEcCtD
Indomethacin—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	6.93e-05	0.000392	CcSEcCtD
Indomethacin—Nausea—Dactinomycin—peripheral nervous system neoplasm	6.91e-05	0.000391	CcSEcCtD
Indomethacin—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	6.9e-05	0.000391	CcSEcCtD
Indomethacin—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	6.88e-05	0.00039	CcSEcCtD
Indomethacin—Dizziness—Vincristine—peripheral nervous system neoplasm	6.87e-05	0.000389	CcSEcCtD
Indomethacin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	6.86e-05	0.000388	CcSEcCtD
Indomethacin—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	6.85e-05	0.000388	CcSEcCtD
Indomethacin—Rash—Alitretinoin—peripheral nervous system neoplasm	6.8e-05	0.000385	CcSEcCtD
Indomethacin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	6.79e-05	0.000385	CcSEcCtD
Indomethacin—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	6.79e-05	0.000384	CcSEcCtD
Indomethacin—CXCL8—cerebellum—peripheral nervous system neoplasm	6.78e-05	0.0251	CbGeAlD
Indomethacin—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	6.77e-05	0.000383	CcSEcCtD
Indomethacin—Bradycardia—Epirubicin—peripheral nervous system neoplasm	6.76e-05	0.000383	CcSEcCtD
Indomethacin—Headache—Alitretinoin—peripheral nervous system neoplasm	6.76e-05	0.000383	CcSEcCtD
Indomethacin—Renal failure—Doxorubicin—peripheral nervous system neoplasm	6.73e-05	0.000381	CcSEcCtD
Indomethacin—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	6.71e-05	0.00038	CcSEcCtD
Indomethacin—Urticaria—Etoposide—peripheral nervous system neoplasm	6.69e-05	0.000379	CcSEcCtD
Indomethacin—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	6.68e-05	0.000378	CcSEcCtD
Indomethacin—Jaundice—Doxorubicin—peripheral nervous system neoplasm	6.67e-05	0.000378	CcSEcCtD
Indomethacin—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	6.67e-05	0.000378	CcSEcCtD
Indomethacin—Abdominal pain—Etoposide—peripheral nervous system neoplasm	6.65e-05	0.000377	CcSEcCtD
Indomethacin—Body temperature increased—Etoposide—peripheral nervous system neoplasm	6.65e-05	0.000377	CcSEcCtD
Indomethacin—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	6.64e-05	0.000376	CcSEcCtD
Indomethacin—Hepatitis—Epirubicin—peripheral nervous system neoplasm	6.64e-05	0.000376	CcSEcCtD
Indomethacin—Vomiting—Vincristine—peripheral nervous system neoplasm	6.61e-05	0.000374	CcSEcCtD
Indomethacin—Asthenia—Cisplatin—peripheral nervous system neoplasm	6.59e-05	0.000373	CcSEcCtD
Indomethacin—Sweating—Doxorubicin—peripheral nervous system neoplasm	6.56e-05	0.000372	CcSEcCtD
Indomethacin—Rash—Vincristine—peripheral nervous system neoplasm	6.55e-05	0.000371	CcSEcCtD
Indomethacin—Dermatitis—Vincristine—peripheral nervous system neoplasm	6.55e-05	0.000371	CcSEcCtD
Indomethacin—Haematuria—Doxorubicin—peripheral nervous system neoplasm	6.53e-05	0.00037	CcSEcCtD
Indomethacin—Headache—Vincristine—peripheral nervous system neoplasm	6.51e-05	0.000369	CcSEcCtD
Indomethacin—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	6.46e-05	0.000366	CcSEcCtD
Indomethacin—Nausea—Alitretinoin—peripheral nervous system neoplasm	6.41e-05	0.000363	CcSEcCtD
Indomethacin—PPARA—cerebellum—peripheral nervous system neoplasm	6.39e-05	0.0237	CbGeAlD
Indomethacin—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	6.39e-05	0.000362	CcSEcCtD
Indomethacin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	6.29e-05	0.000356	CcSEcCtD
Indomethacin—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	6.28e-05	0.000356	CcSEcCtD
Indomethacin—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	6.26e-05	0.000354	CcSEcCtD
Indomethacin—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	6.2e-05	0.000351	CcSEcCtD
Indomethacin—Tinnitus—Epirubicin—peripheral nervous system neoplasm	6.19e-05	0.000351	CcSEcCtD
Indomethacin—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	6.18e-05	0.00035	CcSEcCtD
Indomethacin—Nausea—Vincristine—peripheral nervous system neoplasm	6.17e-05	0.00035	CcSEcCtD
Indomethacin—Flushing—Epirubicin—peripheral nervous system neoplasm	6.16e-05	0.000349	CcSEcCtD
Indomethacin—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	6.15e-05	0.000348	CcSEcCtD
Indomethacin—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	6.15e-05	0.000348	CcSEcCtD
Indomethacin—Asthenia—Etoposide—peripheral nervous system neoplasm	6.04e-05	0.000342	CcSEcCtD
Indomethacin—Pruritus—Etoposide—peripheral nervous system neoplasm	5.96e-05	0.000337	CcSEcCtD
Indomethacin—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	5.93e-05	0.000336	CcSEcCtD
Indomethacin—ABCC1—parotid gland—peripheral nervous system neoplasm	5.89e-05	0.0218	CbGeAlD
Indomethacin—Alopecia—Epirubicin—peripheral nervous system neoplasm	5.87e-05	0.000332	CcSEcCtD
Indomethacin—Vomiting—Cisplatin—peripheral nervous system neoplasm	5.84e-05	0.000331	CcSEcCtD
Indomethacin—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	5.81e-05	0.000329	CcSEcCtD
Indomethacin—Rash—Cisplatin—peripheral nervous system neoplasm	5.79e-05	0.000328	CcSEcCtD
Indomethacin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	5.79e-05	0.000328	CcSEcCtD
Indomethacin—Erythema—Epirubicin—peripheral nervous system neoplasm	5.78e-05	0.000327	CcSEcCtD
Indomethacin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	5.76e-05	0.000326	CcSEcCtD
Indomethacin—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	5.73e-05	0.000324	CcSEcCtD
Indomethacin—Flushing—Doxorubicin—peripheral nervous system neoplasm	5.7e-05	0.000323	CcSEcCtD
Indomethacin—Flatulence—Epirubicin—peripheral nervous system neoplasm	5.7e-05	0.000323	CcSEcCtD
Indomethacin—Tension—Epirubicin—peripheral nervous system neoplasm	5.67e-05	0.000321	CcSEcCtD
Indomethacin—Nervousness—Epirubicin—peripheral nervous system neoplasm	5.62e-05	0.000318	CcSEcCtD
Indomethacin—Dizziness—Etoposide—peripheral nervous system neoplasm	5.57e-05	0.000315	CcSEcCtD
Indomethacin—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	5.49e-05	0.000311	CcSEcCtD
Indomethacin—Nausea—Cisplatin—peripheral nervous system neoplasm	5.46e-05	0.000309	CcSEcCtD
Indomethacin—Vision blurred—Epirubicin—peripheral nervous system neoplasm	5.45e-05	0.000309	CcSEcCtD
Indomethacin—Alopecia—Doxorubicin—peripheral nervous system neoplasm	5.43e-05	0.000308	CcSEcCtD
Indomethacin—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	5.36e-05	0.000304	CcSEcCtD
Indomethacin—Vomiting—Etoposide—peripheral nervous system neoplasm	5.35e-05	0.000303	CcSEcCtD
Indomethacin—Erythema—Doxorubicin—peripheral nervous system neoplasm	5.35e-05	0.000303	CcSEcCtD
Indomethacin—Anaemia—Epirubicin—peripheral nervous system neoplasm	5.34e-05	0.000303	CcSEcCtD
Indomethacin—AKR1C3—cerebellum—peripheral nervous system neoplasm	5.31e-05	0.0197	CbGeAlD
Indomethacin—Rash—Etoposide—peripheral nervous system neoplasm	5.31e-05	0.000301	CcSEcCtD
Indomethacin—Dermatitis—Etoposide—peripheral nervous system neoplasm	5.3e-05	0.0003	CcSEcCtD
Indomethacin—Headache—Etoposide—peripheral nervous system neoplasm	5.27e-05	0.000299	CcSEcCtD
Indomethacin—Flatulence—Doxorubicin—peripheral nervous system neoplasm	5.27e-05	0.000299	CcSEcCtD
Indomethacin—Tension—Doxorubicin—peripheral nervous system neoplasm	5.25e-05	0.000297	CcSEcCtD
Indomethacin—Malaise—Epirubicin—peripheral nervous system neoplasm	5.21e-05	0.000295	CcSEcCtD
Indomethacin—Nervousness—Doxorubicin—peripheral nervous system neoplasm	5.2e-05	0.000294	CcSEcCtD
Indomethacin—Vertigo—Epirubicin—peripheral nervous system neoplasm	5.19e-05	0.000294	CcSEcCtD
Indomethacin—Syncope—Epirubicin—peripheral nervous system neoplasm	5.18e-05	0.000294	CcSEcCtD
Indomethacin—Leukopenia—Epirubicin—peripheral nervous system neoplasm	5.18e-05	0.000293	CcSEcCtD
Indomethacin—Palpitations—Epirubicin—peripheral nervous system neoplasm	5.11e-05	0.000289	CcSEcCtD
Indomethacin—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	5.08e-05	0.000288	CcSEcCtD
Indomethacin—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	5.04e-05	0.000285	CcSEcCtD
Indomethacin—Convulsion—Epirubicin—peripheral nervous system neoplasm	5.01e-05	0.000284	CcSEcCtD
Indomethacin—Nausea—Etoposide—peripheral nervous system neoplasm	5e-05	0.000283	CcSEcCtD
Indomethacin—Hypertension—Epirubicin—peripheral nervous system neoplasm	4.99e-05	0.000283	CcSEcCtD
Indomethacin—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	4.96e-05	0.000281	CcSEcCtD
Indomethacin—Anaemia—Doxorubicin—peripheral nervous system neoplasm	4.94e-05	0.00028	CcSEcCtD
Indomethacin—Chest pain—Epirubicin—peripheral nervous system neoplasm	4.92e-05	0.000279	CcSEcCtD
Indomethacin—Anxiety—Epirubicin—peripheral nervous system neoplasm	4.91e-05	0.000278	CcSEcCtD
Indomethacin—Discomfort—Epirubicin—peripheral nervous system neoplasm	4.86e-05	0.000275	CcSEcCtD
Indomethacin—Malaise—Doxorubicin—peripheral nervous system neoplasm	4.82e-05	0.000273	CcSEcCtD
Indomethacin—Vertigo—Doxorubicin—peripheral nervous system neoplasm	4.81e-05	0.000272	CcSEcCtD
Indomethacin—Syncope—Doxorubicin—peripheral nervous system neoplasm	4.8e-05	0.000272	CcSEcCtD
Indomethacin—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	4.79e-05	0.000271	CcSEcCtD
Indomethacin—Confusional state—Epirubicin—peripheral nervous system neoplasm	4.76e-05	0.000269	CcSEcCtD
Indomethacin—Palpitations—Doxorubicin—peripheral nervous system neoplasm	4.73e-05	0.000268	CcSEcCtD
Indomethacin—Oedema—Epirubicin—peripheral nervous system neoplasm	4.72e-05	0.000267	CcSEcCtD
Indomethacin—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	4.72e-05	0.000267	CcSEcCtD
Indomethacin—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	4.7e-05	0.000266	CcSEcCtD
Indomethacin—Shock—Epirubicin—peripheral nervous system neoplasm	4.64e-05	0.000263	CcSEcCtD
Indomethacin—Convulsion—Doxorubicin—peripheral nervous system neoplasm	4.64e-05	0.000262	CcSEcCtD
Indomethacin—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	4.62e-05	0.000262	CcSEcCtD
Indomethacin—Hypertension—Doxorubicin—peripheral nervous system neoplasm	4.62e-05	0.000262	CcSEcCtD
Indomethacin—Tachycardia—Epirubicin—peripheral nervous system neoplasm	4.61e-05	0.000261	CcSEcCtD
Indomethacin—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	4.56e-05	0.000258	CcSEcCtD
Indomethacin—Chest pain—Doxorubicin—peripheral nervous system neoplasm	4.55e-05	0.000258	CcSEcCtD
Indomethacin—Anxiety—Doxorubicin—peripheral nervous system neoplasm	4.54e-05	0.000257	CcSEcCtD
Indomethacin—Discomfort—Doxorubicin—peripheral nervous system neoplasm	4.5e-05	0.000255	CcSEcCtD
Indomethacin—Anorexia—Epirubicin—peripheral nervous system neoplasm	4.5e-05	0.000255	CcSEcCtD
Indomethacin—Hypotension—Epirubicin—peripheral nervous system neoplasm	4.41e-05	0.00025	CcSEcCtD
Indomethacin—Confusional state—Doxorubicin—peripheral nervous system neoplasm	4.4e-05	0.000249	CcSEcCtD
Indomethacin—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	4.37e-05	0.000247	CcSEcCtD
Indomethacin—Oedema—Doxorubicin—peripheral nervous system neoplasm	4.37e-05	0.000247	CcSEcCtD
Indomethacin—Shock—Doxorubicin—peripheral nervous system neoplasm	4.3e-05	0.000243	CcSEcCtD
Indomethacin—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	4.27e-05	0.000242	CcSEcCtD
Indomethacin—Insomnia—Epirubicin—peripheral nervous system neoplasm	4.27e-05	0.000242	CcSEcCtD
Indomethacin—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	4.26e-05	0.000241	CcSEcCtD
Indomethacin—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	4.24e-05	0.00024	CcSEcCtD
Indomethacin—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	4.22e-05	0.000239	CcSEcCtD
Indomethacin—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	4.21e-05	0.000238	CcSEcCtD
Indomethacin—Somnolence—Epirubicin—peripheral nervous system neoplasm	4.19e-05	0.000238	CcSEcCtD
Indomethacin—Anorexia—Doxorubicin—peripheral nervous system neoplasm	4.16e-05	0.000236	CcSEcCtD
Indomethacin—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	4.15e-05	0.000235	CcSEcCtD
Indomethacin—PTGS2—trigeminal ganglion—peripheral nervous system neoplasm	4.12e-05	0.0152	CbGeAlD
Indomethacin—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	4.1e-05	0.000232	CcSEcCtD
Indomethacin—Hypotension—Doxorubicin—peripheral nervous system neoplasm	4.08e-05	0.000231	CcSEcCtD
Indomethacin—Fatigue—Epirubicin—peripheral nervous system neoplasm	4.07e-05	0.00023	CcSEcCtD
Indomethacin—Pain—Epirubicin—peripheral nervous system neoplasm	4.04e-05	0.000228	CcSEcCtD
Indomethacin—Constipation—Epirubicin—peripheral nervous system neoplasm	4.04e-05	0.000228	CcSEcCtD
Indomethacin—Insomnia—Doxorubicin—peripheral nervous system neoplasm	3.95e-05	0.000224	CcSEcCtD
Indomethacin—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	3.92e-05	0.000222	CcSEcCtD
Indomethacin—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	3.89e-05	0.00022	CcSEcCtD
Indomethacin—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	3.89e-05	0.00022	CcSEcCtD
Indomethacin—Somnolence—Doxorubicin—peripheral nervous system neoplasm	3.88e-05	0.00022	CcSEcCtD
Indomethacin—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	3.86e-05	0.000218	CcSEcCtD
Indomethacin—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	3.84e-05	0.000218	CcSEcCtD
Indomethacin—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	3.8e-05	0.000215	CcSEcCtD
Indomethacin—Fatigue—Doxorubicin—peripheral nervous system neoplasm	3.76e-05	0.000213	CcSEcCtD
Indomethacin—Urticaria—Epirubicin—peripheral nervous system neoplasm	3.75e-05	0.000212	CcSEcCtD
Indomethacin—Pain—Doxorubicin—peripheral nervous system neoplasm	3.73e-05	0.000211	CcSEcCtD
Indomethacin—Constipation—Doxorubicin—peripheral nervous system neoplasm	3.73e-05	0.000211	CcSEcCtD
Indomethacin—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	3.73e-05	0.000211	CcSEcCtD
Indomethacin—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	3.73e-05	0.000211	CcSEcCtD
Indomethacin—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	3.6e-05	0.000204	CcSEcCtD
Indomethacin—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	3.57e-05	0.000202	CcSEcCtD
Indomethacin—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	3.48e-05	0.000197	CcSEcCtD
Indomethacin—Urticaria—Doxorubicin—peripheral nervous system neoplasm	3.47e-05	0.000196	CcSEcCtD
Indomethacin—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	3.45e-05	0.000195	CcSEcCtD
Indomethacin—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	3.45e-05	0.000195	CcSEcCtD
Indomethacin—Asthenia—Epirubicin—peripheral nervous system neoplasm	3.39e-05	0.000192	CcSEcCtD
Indomethacin—Pruritus—Epirubicin—peripheral nervous system neoplasm	3.34e-05	0.000189	CcSEcCtD
Indomethacin—SLCO1A2—cerebellum—peripheral nervous system neoplasm	3.32e-05	0.0123	CbGeAlD
Indomethacin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	3.23e-05	0.000183	CcSEcCtD
Indomethacin—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	3.22e-05	0.000182	CcSEcCtD
Indomethacin—Asthenia—Doxorubicin—peripheral nervous system neoplasm	3.13e-05	0.000177	CcSEcCtD
Indomethacin—Dizziness—Epirubicin—peripheral nervous system neoplasm	3.12e-05	0.000177	CcSEcCtD
Indomethacin—Pruritus—Doxorubicin—peripheral nervous system neoplasm	3.09e-05	0.000175	CcSEcCtD
Indomethacin—Vomiting—Epirubicin—peripheral nervous system neoplasm	3e-05	0.00017	CcSEcCtD
Indomethacin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	2.99e-05	0.000169	CcSEcCtD
Indomethacin—Rash—Epirubicin—peripheral nervous system neoplasm	2.98e-05	0.000168	CcSEcCtD
Indomethacin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	2.97e-05	0.000168	CcSEcCtD
Indomethacin—Headache—Epirubicin—peripheral nervous system neoplasm	2.96e-05	0.000167	CcSEcCtD
Indomethacin—Dizziness—Doxorubicin—peripheral nervous system neoplasm	2.89e-05	0.000163	CcSEcCtD
Indomethacin—Nausea—Epirubicin—peripheral nervous system neoplasm	2.8e-05	0.000159	CcSEcCtD
Indomethacin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	2.78e-05	0.000157	CcSEcCtD
Indomethacin—Rash—Doxorubicin—peripheral nervous system neoplasm	2.75e-05	0.000156	CcSEcCtD
Indomethacin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	2.75e-05	0.000156	CcSEcCtD
Indomethacin—Headache—Doxorubicin—peripheral nervous system neoplasm	2.74e-05	0.000155	CcSEcCtD
Indomethacin—ABCC1—cerebellum—peripheral nervous system neoplasm	2.72e-05	0.0101	CbGeAlD
Indomethacin—Nausea—Doxorubicin—peripheral nervous system neoplasm	2.59e-05	0.000147	CcSEcCtD
Indomethacin—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	2.55e-05	0.00942	CbGeAlD
Indomethacin—PTGS2—C-MYB transcription factor network—HRAS—peripheral nervous system neoplasm	2.31e-05	0.000418	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PPP3R1—peripheral nervous system neoplasm	2.31e-05	0.000418	CbGpPWpGaD
Indomethacin—ABCC2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.3e-05	0.000417	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—PTPN11—peripheral nervous system neoplasm	2.29e-05	0.000414	CbGpPWpGaD
Indomethacin—ABCC1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.27e-05	0.000412	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.27e-05	0.000411	CbGpPWpGaD
Indomethacin—PTGS2—Spinal Cord Injury—MYC—peripheral nervous system neoplasm	2.24e-05	0.000406	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—NME1—peripheral nervous system neoplasm	2.24e-05	0.000405	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—TH—peripheral nervous system neoplasm	2.24e-05	0.000405	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—PTPN11—peripheral nervous system neoplasm	2.23e-05	0.000404	CbGpPWpGaD
Indomethacin—PTGS2—Disease—GNS—peripheral nervous system neoplasm	2.21e-05	0.000401	CbGpPWpGaD
Indomethacin—CXCL8—Cellular responses to stress—TP53—peripheral nervous system neoplasm	2.2e-05	0.000399	CbGpPWpGaD
Indomethacin—SLCO1B1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.2e-05	0.000399	CbGpPWpGaD
Indomethacin—PPARG—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	2.16e-05	0.000391	CbGpPWpGaD
Indomethacin—SLCO1B1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.16e-05	0.000391	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—COX2—peripheral nervous system neoplasm	2.15e-05	0.00039	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	2.15e-05	0.00039	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—ENO2—peripheral nervous system neoplasm	2.13e-05	0.000387	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—ENO2—peripheral nervous system neoplasm	2.13e-05	0.000387	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	2.13e-05	0.000386	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—GNAS—peripheral nervous system neoplasm	2.11e-05	0.000382	CbGpPWpGaD
Indomethacin—ALB—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.07e-05	0.000376	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—ABCB1—peripheral nervous system neoplasm	2.07e-05	0.000375	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—ENO2—peripheral nervous system neoplasm	2.02e-05	0.000366	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.01e-05	0.000365	CbGpPWpGaD
Indomethacin—ABCC1—Disease—ENO2—peripheral nervous system neoplasm	2e-05	0.000362	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.96e-05	0.000355	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	1.95e-05	0.000354	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.92e-05	0.000348	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—NRAS—peripheral nervous system neoplasm	1.92e-05	0.000348	CbGpPWpGaD
Indomethacin—PPARA—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	1.9e-05	0.000344	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.86e-05	0.000337	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—ENO2—peripheral nervous system neoplasm	1.86e-05	0.000337	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.86e-05	0.000337	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—GNS—peripheral nervous system neoplasm	1.85e-05	0.000336	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.85e-05	0.000334	CbGpPWpGaD
Indomethacin—PTGS2—Spinal Cord Injury—TP53—peripheral nervous system neoplasm	1.84e-05	0.000333	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—GNAS—peripheral nervous system neoplasm	1.83e-05	0.000331	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.82e-05	0.000329	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—ERBB2—peripheral nervous system neoplasm	1.81e-05	0.000328	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—BCHE—peripheral nervous system neoplasm	1.8e-05	0.000327	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—BCHE—peripheral nervous system neoplasm	1.8e-05	0.000327	CbGpPWpGaD
Indomethacin—PTGS2—cerebellum—peripheral nervous system neoplasm	1.8e-05	0.00665	CbGeAlD
Indomethacin—PTGDR2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.79e-05	0.000325	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—ABCB1—peripheral nervous system neoplasm	1.79e-05	0.000325	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—IFNB1—peripheral nervous system neoplasm	1.79e-05	0.000325	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.78e-05	0.000322	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—NME1—peripheral nervous system neoplasm	1.78e-05	0.000322	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.76e-05	0.000319	CbGpPWpGaD
Indomethacin—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	1.75e-05	0.000318	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—PTPN11—peripheral nervous system neoplasm	1.75e-05	0.000317	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—ENO2—peripheral nervous system neoplasm	1.73e-05	0.000314	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—ENO2—peripheral nervous system neoplasm	1.73e-05	0.000314	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.72e-05	0.000312	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.72e-05	0.000312	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.72e-05	0.000312	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—COX2—peripheral nervous system neoplasm	1.71e-05	0.00031	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—BCHE—peripheral nervous system neoplasm	1.71e-05	0.000309	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.7e-05	0.000307	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—TH—peripheral nervous system neoplasm	1.7e-05	0.000307	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—TH—peripheral nervous system neoplasm	1.7e-05	0.000307	CbGpPWpGaD
Indomethacin—ABCC4—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	1.68e-05	0.000305	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—ENO2—peripheral nervous system neoplasm	1.67e-05	0.000303	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—KNG1—peripheral nervous system neoplasm	1.66e-05	0.000301	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.63e-05	0.000296	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.63e-05	0.000295	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.63e-05	0.000295	CbGpPWpGaD
Indomethacin—ABCC1—Disease—SLC2A1—peripheral nervous system neoplasm	1.61e-05	0.000292	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—TH—peripheral nervous system neoplasm	1.6e-05	0.000291	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—ENO2—peripheral nervous system neoplasm	1.59e-05	0.000288	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.59e-05	0.000288	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—BCHE—peripheral nervous system neoplasm	1.57e-05	0.000285	CbGpPWpGaD
Indomethacin—ALB—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.56e-05	0.000283	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PPP3R1—peripheral nervous system neoplasm	1.55e-05	0.00028	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.55e-05	0.00028	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	1.52e-05	0.000276	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	1.52e-05	0.000276	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.51e-05	0.000274	CbGpPWpGaD
Indomethacin—ALB—Metabolism—GNS—peripheral nervous system neoplasm	1.5e-05	0.000272	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.5e-05	0.000271	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.49e-05	0.00027	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—TH—peripheral nervous system neoplasm	1.48e-05	0.000268	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—BCHE—peripheral nervous system neoplasm	1.47e-05	0.000266	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—BCHE—peripheral nervous system neoplasm	1.47e-05	0.000266	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—GNAS—peripheral nervous system neoplasm	1.45e-05	0.000263	CbGpPWpGaD
Indomethacin—ALB—Metabolism—NME1—peripheral nervous system neoplasm	1.44e-05	0.00026	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—ENO2—peripheral nervous system neoplasm	1.41e-05	0.000256	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—BCHE—peripheral nervous system neoplasm	1.41e-05	0.000256	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.41e-05	0.000256	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—HRAS—peripheral nervous system neoplasm	1.4e-05	0.000254	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.4e-05	0.000253	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.4e-05	0.000253	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.39e-05	0.000252	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.39e-05	0.000252	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—GNAS—peripheral nervous system neoplasm	1.38e-05	0.000251	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—GNAS—peripheral nervous system neoplasm	1.38e-05	0.000251	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—HGF—peripheral nervous system neoplasm	1.38e-05	0.000251	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	1.38e-05	0.000251	CbGpPWpGaD
Indomethacin—ALB—Metabolism—COX2—peripheral nervous system neoplasm	1.38e-05	0.000251	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—ERBB2—peripheral nervous system neoplasm	1.38e-05	0.00025	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—TH—peripheral nervous system neoplasm	1.38e-05	0.00025	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—TH—peripheral nervous system neoplasm	1.38e-05	0.00025	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—NRAS—peripheral nervous system neoplasm	1.38e-05	0.000249	CbGpPWpGaD
Indomethacin—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.37e-05	0.000248	CbGpPWpGaD
Indomethacin—PPARG—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	1.36e-05	0.000247	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—ABCB1—peripheral nervous system neoplasm	1.36e-05	0.000246	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—ABCB1—peripheral nervous system neoplasm	1.36e-05	0.000246	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.35e-05	0.000244	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GNS—peripheral nervous system neoplasm	1.35e-05	0.000244	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—BCHE—peripheral nervous system neoplasm	1.34e-05	0.000243	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—NRAS—peripheral nervous system neoplasm	1.34e-05	0.000243	CbGpPWpGaD
Indomethacin—PTGS2—Disease—ENO2—peripheral nervous system neoplasm	1.34e-05	0.000243	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—TH—peripheral nervous system neoplasm	1.33e-05	0.000241	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	1.31e-05	0.000238	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—GNAS—peripheral nervous system neoplasm	1.31e-05	0.000237	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—NME1—peripheral nervous system neoplasm	1.29e-05	0.000234	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—ABCB1—peripheral nervous system neoplasm	1.28e-05	0.000233	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.28e-05	0.000232	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—TH—peripheral nervous system neoplasm	1.26e-05	0.000229	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	1.26e-05	0.000228	CbGpPWpGaD
Indomethacin—ALB—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.26e-05	0.000228	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	1.25e-05	0.000227	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—COX2—peripheral nervous system neoplasm	1.24e-05	0.000225	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—AKT1—peripheral nervous system neoplasm	1.24e-05	0.000225	CbGpPWpGaD
Indomethacin—ALB—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.23e-05	0.000224	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GNS—peripheral nervous system neoplasm	1.23e-05	0.000222	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.22e-05	0.000222	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	1.21e-05	0.00022	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—GNAS—peripheral nervous system neoplasm	1.21e-05	0.000218	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—BCHE—peripheral nervous system neoplasm	1.19e-05	0.000216	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.18e-05	0.000214	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—NME1—peripheral nervous system neoplasm	1.18e-05	0.000213	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.14e-05	0.000207	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.14e-05	0.000206	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—COX2—peripheral nervous system neoplasm	1.13e-05	0.000205	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—GNAS—peripheral nervous system neoplasm	1.13e-05	0.000204	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—GNAS—peripheral nervous system neoplasm	1.13e-05	0.000204	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—TH—peripheral nervous system neoplasm	1.12e-05	0.000204	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—ENO2—peripheral nervous system neoplasm	1.12e-05	0.000203	CbGpPWpGaD
Indomethacin—ABCB1—cerebellum—peripheral nervous system neoplasm	1.11e-05	0.00411	CbGeAlD
Indomethacin—UGT1A9—Metabolism—ABCB1—peripheral nervous system neoplasm	1.1e-05	0.0002	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.1e-05	0.0002	CbGpPWpGaD
Indomethacin—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.1e-05	0.0002	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.09e-05	0.000198	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—GNAS—peripheral nervous system neoplasm	1.08e-05	0.000197	CbGpPWpGaD
Indomethacin—PTGS2—Disease—SLC2A1—peripheral nervous system neoplasm	1.08e-05	0.000196	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	1.08e-05	0.000196	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.06e-05	0.000193	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	1.06e-05	0.000191	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—NRAS—peripheral nervous system neoplasm	1.05e-05	0.00019	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—GNAS—peripheral nervous system neoplasm	1.03e-05	0.000187	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—TP53—peripheral nervous system neoplasm	1.03e-05	0.000186	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.01e-05	0.000183	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—PTPN11—peripheral nervous system neoplasm	1.01e-05	0.000183	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—HRAS—peripheral nervous system neoplasm	1.01e-05	0.000182	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	9.83e-06	0.000178	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—HRAS—peripheral nervous system neoplasm	9.81e-06	0.000178	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—MYC—peripheral nervous system neoplasm	9.79e-06	0.000177	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.68e-06	0.000175	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	9.66e-06	0.000175	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	9.63e-06	0.000174	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—BCHE—peripheral nervous system neoplasm	9.49e-06	0.000172	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—GNAS—peripheral nervous system neoplasm	9.17e-06	0.000166	CbGpPWpGaD
Indomethacin—PPARA—Gene Expression—MYC—peripheral nervous system neoplasm	9.14e-06	0.000166	CbGpPWpGaD
Indomethacin—ALB—Metabolism—ENO2—peripheral nervous system neoplasm	9.08e-06	0.000165	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.05e-06	0.000164	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PTPN11—peripheral nervous system neoplasm	9e-06	0.000163	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—ABCB1—peripheral nervous system neoplasm	9e-06	0.000163	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—TH—peripheral nervous system neoplasm	8.92e-06	0.000162	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—AKT1—peripheral nervous system neoplasm	8.88e-06	0.000161	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	8.87e-06	0.000161	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.78e-06	0.000159	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—AKT1—peripheral nervous system neoplasm	8.67e-06	0.000157	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ENO2—peripheral nervous system neoplasm	8.15e-06	0.000148	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	7.96e-06	0.000144	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism—AKT1—peripheral nervous system neoplasm	7.78e-06	0.000141	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—HRAS—peripheral nervous system neoplasm	7.69e-06	0.000139	CbGpPWpGaD
Indomethacin—ALB—Metabolism—BCHE—peripheral nervous system neoplasm	7.67e-06	0.000139	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.63e-06	0.000138	CbGpPWpGaD
Indomethacin—ALB—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	7.61e-06	0.000138	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	7.49e-06	0.000136	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ENO2—peripheral nervous system neoplasm	7.43e-06	0.000135	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.36e-06	0.000133	CbGpPWpGaD
Indomethacin—ALB—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.32e-06	0.000133	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—GNAS—peripheral nervous system neoplasm	7.28e-06	0.000132	CbGpPWpGaD
Indomethacin—ALB—Metabolism—TH—peripheral nervous system neoplasm	7.22e-06	0.000131	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	7.19e-06	0.00013	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—ABCB1—peripheral nervous system neoplasm	7.14e-06	0.000129	CbGpPWpGaD
Indomethacin—ABCC1—Disease—ERBB2—peripheral nervous system neoplasm	7.11e-06	0.000129	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	6.99e-06	0.000127	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.93e-06	0.000126	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—BCHE—peripheral nervous system neoplasm	6.89e-06	0.000125	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.86e-06	0.000124	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—AKT1—peripheral nervous system neoplasm	6.79e-06	0.000123	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	6.72e-06	0.000122	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—AKT1—peripheral nervous system neoplasm	6.61e-06	0.00012	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.57e-06	0.000119	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—MYC—peripheral nervous system neoplasm	6.55e-06	0.000119	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—TH—peripheral nervous system neoplasm	6.48e-06	0.000117	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.41e-06	0.000116	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.35e-06	0.000115	CbGpPWpGaD
Indomethacin—PPARA—Gene Expression—AKT1—peripheral nervous system neoplasm	6.34e-06	0.000115	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	6.32e-06	0.000115	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	6.28e-06	0.000114	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—NRAS—peripheral nervous system neoplasm	6.07e-06	0.00011	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PTPN11—peripheral nervous system neoplasm	6.04e-06	0.000109	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.99e-06	0.000109	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	5.91e-06	0.000107	CbGpPWpGaD
Indomethacin—ALB—Metabolism—GNAS—peripheral nervous system neoplasm	5.89e-06	0.000107	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.81e-06	0.000105	CbGpPWpGaD
Indomethacin—ALB—Metabolism—ABCB1—peripheral nervous system neoplasm	5.78e-06	0.000105	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—AKT1—peripheral nervous system neoplasm	5.69e-06	0.000103	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.63e-06	0.000102	CbGpPWpGaD
Indomethacin—ABCC1—Disease—NRAS—peripheral nervous system neoplasm	5.41e-06	9.81e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.41e-06	9.8e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.39e-06	9.76e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GNAS—peripheral nervous system neoplasm	5.29e-06	9.58e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	5.19e-06	9.4e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	5.16e-06	9.35e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—MYC—peripheral nervous system neoplasm	5.04e-06	9.13e-05	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—AKT1—peripheral nervous system neoplasm	4.93e-06	8.93e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	4.82e-06	8.73e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—ERBB2—peripheral nervous system neoplasm	4.77e-06	8.65e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.76e-06	8.61e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	4.73e-06	8.57e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—TP53—peripheral nervous system neoplasm	4.64e-06	8.41e-05	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—AKT1—peripheral nervous system neoplasm	4.54e-06	8.23e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.44e-06	8.05e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—HRAS—peripheral nervous system neoplasm	4.44e-06	8.05e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.25e-06	7.7e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—HRAS—peripheral nervous system neoplasm	3.96e-06	7.17e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—AKT1—peripheral nervous system neoplasm	3.92e-06	7.1e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.75e-06	6.8e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—AKT1—peripheral nervous system neoplasm	3.74e-06	6.77e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—AKT1—peripheral nervous system neoplasm	3.74e-06	6.77e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—NRAS—peripheral nervous system neoplasm	3.63e-06	6.58e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—AKT1—peripheral nervous system neoplasm	3.53e-06	6.4e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—AKT1—peripheral nervous system neoplasm	3.5e-06	6.33e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MYC—peripheral nervous system neoplasm	3.38e-06	6.13e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—AKT1—peripheral nervous system neoplasm	3.25e-06	5.89e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—AKT1—peripheral nervous system neoplasm	3.04e-06	5.5e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—AKT1—peripheral nervous system neoplasm	3.04e-06	5.5e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—AKT1—peripheral nervous system neoplasm	2.93e-06	5.3e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—AKT1—peripheral nervous system neoplasm	2.78e-06	5.04e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—HRAS—peripheral nervous system neoplasm	2.66e-06	4.81e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—AKT1—peripheral nervous system neoplasm	2.48e-06	4.48e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—AKT1—peripheral nervous system neoplasm	2.35e-06	4.25e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—AKT1—peripheral nervous system neoplasm	1.97e-06	3.56e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—AKT1—peripheral nervous system neoplasm	1.59e-06	2.88e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	1.43e-06	2.59e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	1.39e-06	2.52e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	1.3e-06	2.36e-05	CbGpPWpGaD
